Back
Novo Nordisk A/S Vs. Vertex Pharmaceuticals Industry Stock Comparison
Buy
62
NVO
Novo Nordisk A/S
Last Price:
128.65
Seasonality Move:
4.82%
Buy
70
VRTX
Vertex Pharmaceuticals
Last Price:
419.22
Seasonality Move:
8.99%
Buy
62
Novo Nordisk A/S (NVO)
is a Buy
Is Novo Nordisk A/S a Buy, Sell or Hold?
- The current Novo Nordisk A/S [NVO] share price is $126.69. The Score for NVO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- NVO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $418.82. The Score for VRTX is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $126.69
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $418.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing slight selling pressure.
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 51.73 | Buy |
| Chaikin Money Flow: | -2998751 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
VRTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.24 | Buy |
| Relative Strength Index (14 RSI): | 65.76 | Buy |
| Chaikin Money Flow: | -15832 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (394.62 - 406.22) | Buy |
| Bollinger Bands (100): | (402.36 - 427.66) | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 126.26 | Buy |
| 20-day SMA: | 125.5 | Buy |
| 50-day SMA: | 127.3 | Sell |
| 200-day SMA: | 106.82 | Buy |
| 8-day EMA: | 126.04 | Buy |
| 20-day EMA: | 126.02 | Buy |
| 50-day EMA: | 124.71 | Buy |
| 200-day EMA: | 108.84 | Buy |
VRTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 403 | Buy |
| 20-day SMA: | 399.7 | Buy |
| 50-day SMA: | 408.02 | Buy |
| 200-day SMA: | 385.37 | Buy |
| 8-day EMA: | 405.88 | Buy |
| 20-day EMA: | 403.28 | Buy |
| 50-day EMA: | 406.25 | Buy |
| 200-day EMA: | 387.17 | Buy |
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and an increase next year of $0.66 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.78 per share, an increase this year of $1.97 per share, and an increase next year of $1.13 per share.
Novo Nordisk A/S Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vertex Pharmaceuticals Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||